Latest Health News

The ACCC has approved Elders Limited’s acquisition of Delta Agribusiness, contingent on Elders divesting six Delta retail stores in Western Australia to preserve local competition.

EDU Holdings Limited is set to renew its on-market share buyback program, aiming to repurchase up to 14.4 million shares over the next year, continuing its strategy to enhance shareholder value.

Anatara Lifesciences has completed the first tranche of its two-part share placement, issuing over 33 million ordinary shares to professional investors. This move marks a significant step in the company’s capital raising efforts amid ongoing product development.

AKORA Resources has successfully completed a $2.9 million capital raise and commenced a trenching program at its flagship Bekisopa Iron Ore Project in Madagascar, reinforcing strong local and governmental support as it progresses towards production.

Adamantem Capital Management has completed its due diligence on Apiam Animal Health and extended its exclusivity period to negotiate a potential $0.87 per share acquisition. The deal remains subject to approvals and binding agreements.

Immuron Limited has taken a significant step forward by submitting an Investigational New Drug application to the FDA for IMM-529, targeting Clostridioides difficile infection. The company aims to start Phase 2 trials in early 2026, addressing a critical unmet need in infectious disease treatment.

Theta Gold Mines Limited has had its trading suspension lifted immediately following the release of a funding transaction announcement, signaling renewed market activity for the gold miner.

Seafarms Group Limited has resumed trading on the ASX following the lifting of its suspension, triggered by the lodgement of its annual financial report.

Assetora Limited has released its audited FY25 financial report showing a significant reduction in losses and a strengthened capital position, highlighted by the reopening of the DomaCom Fund and a $3 million private placement. The company aims to leverage these developments to accelerate growth in funds under management.

Aumake Limited has launched Bio-Basic Ergothioneine, marking the debut of its innovative capital-light incubation model aimed at scaling premium health brands with minimal upfront investment.

Micro-X Ltd has received a $5.08 million R&D tax incentive rebate for FY25, with an additional $0.31 million pending approval, reinforcing its innovation-driven growth in medical imaging technology.

Jayride Group Limited’s shares have been suspended from trading on the ASX following concerns over its financial health and a critical auditor’s disclaimer. The suspension highlights significant regulatory scrutiny and investor risk.